Cervical cancer immunotherapy: facts and hopes

L Ferrall, KY Lin, RBS Roden, CF Hung, TC Wu - Clinical Cancer Research, 2021 - AACR
It is a sad fact that despite being almost completely preventable through human
papillomavirus (HPV) vaccination and screening, cervical cancer remains the fourth most …

Next generation of immune checkpoint therapy in cancer: new developments and challenges

JA Marin-Acevedo, B Dholaria, AE Soyano… - Journal of hematology & …, 2018 - Springer
Immune checkpoints consist of inhibitory and stimulatory pathways that maintain self-
tolerance and assist with immune response. In cancer, immune checkpoint pathways are …

Next generation antibody drugs: pursuit of the'high-hanging fruit'

PJ Carter, GA Lazar - Nature Reviews Drug Discovery, 2018 - nature.com
Antibodies are the most rapidly growing drug class and have a major impact on human
health, particularly in oncology, autoimmunity and chronic inflammatory diseases. Many of …

Oncolytic viruses in cancer treatment: a review

SE Lawler, MC Speranza, CF Cho, EA Chiocca - JAMA oncology, 2017 - jamanetwork.com
Importance Oncolytic viruses (OVs) are emerging as important agents in cancer treatment.
Oncolytic viruses offer the attractive therapeutic combination of tumor-specific cell lysis …

Targeting co-stimulatory molecules in autoimmune disease

NM Edner, G Carlesso, JS Rush… - Nature Reviews Drug …, 2020 - nature.com
Therapeutic targeting of immune checkpoints has garnered significant attention in the area
of cancer immunotherapy, in which efforts have focused in particular on cytotoxic T …

The promise and challenges of immune agonist antibody development in cancer

PA Mayes, KW Hance, A Hoos - Nature Reviews Drug Discovery, 2018 - nature.com
Immune cell functions are regulated by co-inhibitory and co-stimulatory receptors. The first
two generations of cancer immunotherapy agents consist primarily of antagonist antibodies …

Biomimetic nanoparticles deliver mRNAs encoding costimulatory receptors and enhance T cell mediated cancer immunotherapy

W Li, X Zhang, C Zhang, J Yan, X Hou, S Du… - Nature …, 2021 - nature.com
Antibodies targeting costimulatory receptors of T cells have been developed for the
activation of T cell immunity in cancer immunotherapy. However, costimulatory molecule …

[HTML][HTML] Biological drug and drug delivery-mediated immunotherapy

Q **ao, X Li, Y Li, Z Wu, C Xu, Z Chen, W He - Acta Pharmaceutica Sinica B, 2021 - Elsevier
The initiation and development of major inflammatory diseases, ie, cancer, vascular
inflammation, and some autoimmune diseases are closely linked to the immune system …

Multifunctional Au Modified Ti3C2-MXene for Photothermal/Enzyme Dynamic/Immune Synergistic Therapy

X Chang, Q Wu, Y Wu, X **, J Cao, H Chu, Q Liu… - Nano Letters, 2022 - ACS Publications
Ti3C2-MXene-based composites provide multifunctional interfaces in diagnosis and
treatment of tumors. Herein, we proposed a multifunctional nanoplatform based on Ti3C2 …

Immunotherapy in renal cell carcinoma: the future is now

A Deleuze, J Saout, F Dugay, B Peyronnet… - International Journal of …, 2020 - mdpi.com
Renal cell carcinoma is the third type of urologic cancer and has a poor prognosis with 30%
of metastatic patients at diagnosis. The antiangiogenics and targeted immunotherapies led …